This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ moxifloxacin (antibiotic)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Respiratory Tract Infections: Moxifloxacin is commonly used to treat respiratory tract infections caused by susceptible bacteria. This includes:

    • Acute bacterial sinusitis
    • Acute exacerbations of chronic bronchitis
    • Community-acquired pneumonia
  2. Skin and Soft Tissue Infections: Moxifloxacin may be prescribed to treat skin and soft tissue infections caused by susceptible bacteria, including:

    • Cellulitis
    • Abscesses
    • Wound infections
  3. Intra-Abdominal Infections: Moxifloxacin can be used to treat intra-abdominal infections such as peritonitis and intra-abdominal abscesses.

  4. Urinary Tract Infections (UTIs): Moxifloxacin is effective against UTIs caused by susceptible bacteria, including complicated and uncomplicated UTIs.

  5. Sexually Transmitted Infections (STIs): Moxifloxacin may be used to treat certain STIs caused by susceptible bacteria, such as gonorrhea.

  6. Eye Infections: Moxifloxacin eye drops are prescribed to treat bacterial conjunctivitis (pink eye) and corneal ulcers caused by susceptible organisms.

  7. Safety Considerations: Moxifloxacin, like other fluoroquinolones, may be associated with side effects such as gastrointestinal disturbances (nausea, vomiting, diarrhea), headache, dizziness, and photosensitivity. Rare but serious adverse effects include tendonitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is essential to use moxifloxacin cautiously, especially in patients with a history of tendon disorders or myasthenia gravis.

  8. Bacterial Resistance: Overuse or misuse of moxifloxacin can lead to the development of bacterial resistance, reducing its effectiveness in treating infections.

  9. Interactions: Moxifloxacin may interact with other medications, including antacids containing magnesium or aluminum, sucralfate, and certain medications that prolong the QT interval. It is essential to inform your healthcare provider about all medications you are taking before starting moxifloxacin treatment.

  10. Duration of Treatment: The duration of moxifloxacin treatment varies depending on the type and severity of the infection. It is crucial to complete the prescribed course of treatment as directed by your healthcare provider, even if symptoms improve before the medication is finished.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of moxifloxacin (antibiotic) On Probiotics

Bacteria Impacted by moxifloxacin (antibiotic)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

Impact of moxifloxacin (antibiotic) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]